Search Results - "Gizurarson, S"

Localized rotational activation in the left atrium during human atrial fibrillation: Relationship to complex fractionated atrial electrograms and low-voltage zones by Ghoraani, B., PhD, Dalvi, R., MSc, Gizurarson, S., MD, PhD, Das, M., MBBS, MRCP(UK), Ha, A., MD, FRCPC, Suszko, A., MSc, Krishnan, S., PhD, Chauhan, V.S., MD, FRCPC

“…Background In humans, the existence of rotors or reentrant sources maintaining atrial fibrillation (AF) and the underlying electroanatomic substrate has not…”
Get full text

Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia by Huppertz, Berthold, Meiri, Hamutal, Gizurarson, Sveinbjorn, Osol, George, Sammar, Marei

“…Pre-eclampsia affects 2-7% of all pregnant women and is a major cause of maternal and fetal morbidity and mortality. The etiology of pre-eclampsia is still…”
Get full text

Atrial decremental evoked potentials accurately determine the critical isthmus of intra-atrial re-entrant tachycardia by Bhaskaran, Abhishek, Gizurarson, S, Porta-Sánchez, Andreu, Massé, Stéphane, Nair, Krishnakumar, Nanthakumar, Kumaraswamy

Get full text

Evaluation of in vitro mucoadhesiveness and texture profile analysis of doxycycline in situ hydrogels by Patlolla, V G R, Holbrook, W P, Gizurarson, S, Kristmundsdottir, P

“…Delivery of active ingredients to the oral mucosa from topically applied formulations reduces side effects from systemic administration and enhances the…”
Get more information

The effect of D-(+)-glucosamine, N-acetyl-D-glucosamine and tetraethylene glycol on the stability of oxytocin in aqueous solution by Ghasemisarabbadieh, M, Sigurdsson, S J, Dong, F V Nu, Gizurarson, S, Sveinbjörnsson, B R

“…The aim of the present study was to identify the effect of D-(+)-glucosamine, N-acetyl-D-glucosamine, tetraethyleneglycol, and the mixture of these additives…”
Get more information

Potential negative consequences of non-consented switch of inhaled medications and devices in asthma patients by Björnsdóttir, U S, Gizurarson, S, Sabale, U

“…Asthma requires individually tailored and careful management to control and prevent symptoms and exacerbations. Selection of the most appropriate treatment is…”
Get more information

Bipolar ablation for deep intra-myocardial circuits: human ex vivo development and in vivo experience by Gizurarson, Sigfus, Spears, Danna, Sivagangabalan, Gopal, Farid, Talha, Ha, Andrew C T, Massé, Stéphane, Kusha, Marjan, Chauhan, Vijay S, Nair, Krishnakumar, Harris, Louise, Downar, Eugene, Nanthakumar, Kumaraswamy

“…Current conventional ablation strategies for ventricular tachycardia (VT) aim to interrupt reentrant circuits by creating ablation lesions. However, the…”
Get full text

OC01.04: Aspirin versus placebo in pregnancies at high‐risk of preterm pre‐eclampsia: a multicentre, double‐blind, placebo‐controlled trial by Rolnik, D., Wright, D., Poon, L., O'Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., Molina, F., Perisco, N., Jani, J., Plasencia, W., Papaioannou, G., Tennebaum Gavish, K., Meiri, H., Gizurarson, S., Nicolaides, K.H.

Get full text

Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β₂ -agonists in obstructive lung diseases: a population-based, observational study by Björnsdóttir, U S, Sigurðardóttir, S T, Jonsson, J S, Jonsson, M, Telg, G, Thuresson, M, Naya, I, Gizurarson, S

“…In 2010, the Icelandic government introduced a new cost-saving policy that limited reimbursement of fixed inhaled corticosteroid/long-acting β₂ -agonist…”
Get more information

SAFETY OF RENAL SYMPATHETIC DENERVATION FOLLOWING RECENT MYOCARDIAL INFARCTION by Gizurarson, S, Jackson, N, King, B, Ramadeen, A, Zamiri, N, Porta-Sanchez, A, Al-Hesayen, A, Graham, J, Kusha, M, Masse, S, Lai, P, Dorian, P, Nanthakumar, K

Get full text

RENAL SYMPATHETIC DENERVATION FOLLOWING MYOCARDIAL INFARCTION AND ITS SUBSEQUENT CARDIAC ELECTROPHYSIOLOGICAL EFFECTS by Kumar Nair, G Krishna, Gizurarson, S, Jackson, N, King, B, Hu, X, Ramadeen, A, Zamiri, N, Porta-Sanchez, A, Kusha, M, Massé, S, Lai, P.F, Al-Hesayen, A, Graham, J.J, Dorian, P, Nanthakumar, K

Get full text

Is There an Ideal Strategy to Maximize Endo- and Epicardial Late Potentials Mapping in Patients Undergoing Ablation for Ischemic Ventricular Tachycardia? by Roshan, J, Gizurarson, S, Kusha, M, Dimagiba, L, Khan, K, Masse, S, Harris, L, Downar, E, Nanthakumar, K

Get full text

One-Year Mortality Outcomes Following Ventricular Tachycardia Ablation in Octogenarians by Das, M, Roshan, J, Khan, F.Z, Wanounou, L, Chemello, D, Spears, D.A, Cameron, D, Harris, L, Nair, K, Ha, A.C, Chauhan, V.S, Gizurarson, S, Downar, E, Nanthakumar, K

Get full text

Gastrin Elevation Following Proton Pump Inhibitor Therapy is Related to dose Per Body Weight by Helgadóttir, Hólmfrídur, Björnsson, Einar, Gizurarson, Sveinbjörn S, Metz, David C

Get full text

Effects of complete heart block on myocardial function, morphology, and energy metabolism in the rat by Gizurarson, S., Lorentzon, M., Råmunddal, T., Waagstein, F., Bergfeldt, L., Omerovic, E.

“…Aims Severe sustained bradycardia may cause acute and possibly chronic congestive heart failure (CHF). The aim of this study was to investigate acute and…”
Get full text

Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial by Blomström-Lundqvist, Carina, Gizurarson, Sigfus, Schwieler, Jonas, Jensen, Steen M, Bergfeldt, Lennart, Kennebäck, Göran, Rubulis, Aigars, Malmborg, Helena, Raatikainen, Pekka, Lönnerholm, Stefan, Höglund, Niklas, Mörtsell, David

“…IMPORTANCE: Quality of life is not a standard primary outcome in ablation trials, even though symptoms drive the indication. OBJECTIVE: To assess quality of…”
Get full text

The Effect of Cilia and the Mucociliary Clearance on Successful Drug Delivery by Gizurarson, Sveinbjörn

“…Nasal mucociliary clearance is one of the most important factors affecting nasal delivery of drugs and vaccines. This is also the most important physiological…”
Get full text

Intranasal absorption of buprenorphine — in vivo bioavailability study in sheep by Lindhardt, Karsten, Ravn, Carsten, Gizurarson, Sveinbjörn, Bechgaard, Erik

“…The bioavailability of buprenorphine, HCl (BPP) in sheep after nasal administration of two formulations has been studied. 0.9 mg BPP in 150 μl was administered…”
Get full text

Optimal delivery of vaccines : clinical pharmacokinetic considerations by GIZURARSON, S

Get full text

Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies by Horváth, A, Andersen, I, Junker, K, Lyck Fogh-Schultz, B, Holm Nielsen, E, Gizurarson, S, Andersen, O, Kármán, J, Rajnavölgyi, E, Erdei, A, Svehag, S.-E

“…Serum amyloid P component (SAP) binds in vitro Ca 2+-dependently to several ligands including oligosaccharides with terminal mannose and galactose. We have…”
Get full text